Your browser doesn't support javascript.
loading
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
Bridge, Simon H; Sheridan, David A; Felmlee, Daniel J; Crossey, Mary M E; Fenwick, Fiona I; Lanyon, Clare V; Dubuc, Geneviève; Seidah, Nabil G; Davignon, Jean; Thomas, Howard C; Taylor-Robinson, Simon D; Toms, Geoffrey L; Neely, R Dermot G; Bassendine, Margaret F.
Afiliação
  • Bridge SH; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom. Electronic address: simon.bridge@northumbria.ac.uk.
  • Sheridan DA; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Institute of Translational & Stratified Medicine, Plymouth University Peninsula School of Medicine & Dentistry, United Kingdom.
  • Felmlee DJ; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Inserm U1110, University of Strasbourg and Center for Liver and Digestive Diseases, Strasbourg University Hospitals, 3 Rue Koeberlé, F-67000 Strasbourg, France.
  • Crossey MM; Liver Unit, Department of Medicine, Imperial College London, St Mary's Hospital Campus, Praed Street, London, United Kingdom.
  • Fenwick FI; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Lanyon CV; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.
  • Dubuc G; Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montréal (IRCM), Montréal, Canada; University of Montréal, Montréal, Canada.
  • Seidah NG; Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montréal, Montréal, Canada; University of Montréal, Montréal, Canada.
  • Davignon J; Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montréal (IRCM), Montréal, Canada; University of Montréal, Montréal, Canada.
  • Thomas HC; Liver Unit, Department of Medicine, Imperial College London, St Mary's Hospital Campus, Praed Street, London, United Kingdom.
  • Taylor-Robinson SD; Liver Unit, Department of Medicine, Imperial College London, St Mary's Hospital Campus, Praed Street, London, United Kingdom.
  • Toms GL; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Neely RD; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Clinical Biochemistry, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, United Kingdom.
  • Bassendine MF; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom. Electronic address: margaret.bassendine@newcastle.ac.uk.
J Hepatol ; 62(4): 763-70, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25463543
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Vírion / Serina Endopeptidases / Hepacivirus / Hepatite C Crônica / Pró-Proteína Convertases / LDL-Colesterol Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Vírion / Serina Endopeptidases / Hepacivirus / Hepatite C Crônica / Pró-Proteína Convertases / LDL-Colesterol Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2015 Tipo de documento: Article